Qube Research & Technologies (QRT)’s CorMedix CRMD Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio CRMD Stock Details CRMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-637,497	Closed	-$7.41M	–	3727
2025 Q3	$7.41M	Buy	637,497 +422,277	+196%	+$5.11M	0.01%	1500
2025 Q2	$2.65M	Buy	215,220 +91,720	+74%	+$1.01M	﹤0.01%	2063
2025 Q1	$761K	Buy	+123,500	New	+$1.28M	﹤0.01%	2377
2023 Q2	–	Sell	-12,938	Closed	-$53.6K	–	2484
2023 Q1	$53.6K	Sell	12,938 -22,707	-64%	-$92.9K	﹤0.01%	2219
2022 Q4	$150K	Buy	35,645 +8,685	+32%	+$30.7K	﹤0.01%	1896
2022 Q3	$76K	Sell	26,960 -4,340	-14%	-$18.1K	﹤0.01%	2049
2022 Q2	$126K	Buy	+31,300	New	+$116K	﹤0.01%	1856
2021 Q3	–	Sell	-28,771	Closed	-$197K	–	2294
2021 Q2	$197K	Buy	+28,771	New	+$229K	﹤0.01%	1801

Other funds holding CRMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

OAM

Oberweis Asset Management Lisle, Illinois $4.84B AUM 160.95% 1-Year Est. Return

Qube Research & Technologies (QRT)'s CRMD Position: Q4 2025 in Review

Qube Research & Technologies (QRT) sold out of CorMedix (CRMD) in Q4 2025, closing a stake of 637,497 shares — an estimated $7.41M sold.

Qube Research & Technologies (QRT) first reported a position in CRMD in Q2 2021 and held it in 8 quarters. The position peaked at $7.41M in Q3 2025. 198 funds tracked by Wall St. Rank hold CRMD as of Q4 2025.

Qube Research & Technologies (QRT) reported no remaining CorMedix position as of Q4 2025 after selling out during the quarter.
Qube Research & Technologies (QRT) sold 637,497 CorMedix shares in Q4 2025, an estimated $7.41M.
Qube Research & Technologies (QRT) first reported a position in CorMedix in Q2 2021 and held it in 8 quarters.
Qube Research & Technologies (QRT)'s CorMedix position peaked at $7.41M in Q3 2025.
198 funds tracked by Wall St. Rank held CorMedix as of Q4 2025.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q4 2025, filed 17 Feb 2026.